Xilio Therapeutics
XLO
#9669
Rank
HK$0.32 B
Marketcap
HK$6.56
Share price
-7.00%
Change (1 day)
10.42%
Change (1 year)

P/S ratio for Xilio Therapeutics (XLO)

P/S ratio as of March 2025 (TTM): 9.84

According to Xilio Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.17. At the end of 2024 the company had a P/S ratio of 7.26.

P/S ratio history for Xilio Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.26
2023N/A
2022N/A
2021N/A